Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions

Modern in vitro technologies for preclinical research, including organ-on-a-chip, organoids- and assembloid-based systems, have rapidly emerged as pivotal tools for elucidating disease mechanisms and assessing the efficacy of putative therapeutics. In this context, advanced in vitro models of Parkin...

Full description

Bibliographic Details
Main Authors: Alp Ozgun, David J. Lomboni, Amy Aylsworth, Allison Macdonald, William A. Staines, Marzia Martina, Michael G. Schlossmacher, Joseph S. Tauskela, John Woulfe, Fabio Variola
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Materials Today Bio
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006424000516
_version_ 1797258685107404800
author Alp Ozgun
David J. Lomboni
Amy Aylsworth
Allison Macdonald
William A. Staines
Marzia Martina
Michael G. Schlossmacher
Joseph S. Tauskela
John Woulfe
Fabio Variola
author_facet Alp Ozgun
David J. Lomboni
Amy Aylsworth
Allison Macdonald
William A. Staines
Marzia Martina
Michael G. Schlossmacher
Joseph S. Tauskela
John Woulfe
Fabio Variola
author_sort Alp Ozgun
collection DOAJ
description Modern in vitro technologies for preclinical research, including organ-on-a-chip, organoids- and assembloid-based systems, have rapidly emerged as pivotal tools for elucidating disease mechanisms and assessing the efficacy of putative therapeutics. In this context, advanced in vitro models of Parkinson's Disease (PD) offer the potential to accelerate drug discovery by enabling effective platforms that recapitulate both physiological and pathological attributes of the in vivo environment. Although these systems often aim at replicating the PD-associated loss of dopaminergic (DA) neurons, only a few have modelled the degradation of dopaminergic pathways as a way to mimic the disruption of downstream regulation mechanisms that define the characteristic motor symptoms of the disease. To this end, assembloids have been successfully employed to recapitulate neuronal pathways between distinct brain regions. However, the investigation and characterization of these connections through neural tracing and electrophysiological analysis remain a technically challenging and time-consuming process. Here, we present a novel bioengineered platform consisting of surface-grown midbrain and striatal organoids at opposite sides of a self-assembled DA pathway. In particular, dopaminergic neurons and striatal GABAergic neurons spontaneously form DA connections across a microelectrode array (MEA), specifically integrated for the real-time monitoring of electrophysiological development and stimuli response. Calcium imaging data showed spiking synchronicity of the two organoids forming the inter-organoid pathways (IOPs) demonstrating that they are functionally connected. MEA recordings confirm a more robust response to the DA neurotoxin 6-OHDA compared to midbrain organoids alone, thereby validating the potential of this technology to generate highly tractable, easily extractable real-time functional readouts to investigate the dysfunctional dopaminergic network of PD patients.
first_indexed 2024-03-08T03:35:38Z
format Article
id doaj.art-d2bae2e1d0ce40cf9af33ace061c32c7
institution Directory Open Access Journal
issn 2590-0064
language English
last_indexed 2024-04-24T22:57:27Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj.art-d2bae2e1d0ce40cf9af33ace061c32c72024-03-18T04:34:22ZengElsevierMaterials Today Bio2590-00642024-04-0125100992Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regionsAlp Ozgun0David J. Lomboni1Amy Aylsworth2Allison Macdonald3William A. Staines4Marzia Martina5Michael G. Schlossmacher6Joseph S. Tauskela7John Woulfe8Fabio Variola9Department of Mechanical Engineering, Faculty of Engineering, University of Ottawa, Ottawa, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Program in Neuroscience, Ottawa Hospital Research Institute, Ottawa, CanadaDepartment of Mechanical Engineering, Faculty of Engineering, University of Ottawa, Ottawa, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, CanadaHuman Health Therapeutics Research Centre, National Research Council of Canada, Ottawa, CanadaDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Program in Neuroscience, Ottawa Hospital Research Institute, Ottawa, CanadaDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, CanadaHuman Health Therapeutics Research Centre, National Research Council of Canada, Ottawa, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, CanadaDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Program in Neuroscience, Ottawa Hospital Research Institute, Ottawa, Canada; University of Ottawa Brain and Mind Research Institute, Ottawa, Canada; Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, CanadaHuman Health Therapeutics Research Centre, National Research Council of Canada, Ottawa, CanadaDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Department of Pathology, The Ottawa Hospital, Ottawa, Canada; Corresponding author. Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.Department of Mechanical Engineering, Faculty of Engineering, University of Ottawa, Ottawa, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Ottawa-Carleton Institute for Biomedical Engineering (OCIBME), Ottawa, Canada; Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada; Corresponding author. Department of Mechanical Engineering, Faculty of Engineering, University of Ottawa, Ottawa, Canada.Modern in vitro technologies for preclinical research, including organ-on-a-chip, organoids- and assembloid-based systems, have rapidly emerged as pivotal tools for elucidating disease mechanisms and assessing the efficacy of putative therapeutics. In this context, advanced in vitro models of Parkinson's Disease (PD) offer the potential to accelerate drug discovery by enabling effective platforms that recapitulate both physiological and pathological attributes of the in vivo environment. Although these systems often aim at replicating the PD-associated loss of dopaminergic (DA) neurons, only a few have modelled the degradation of dopaminergic pathways as a way to mimic the disruption of downstream regulation mechanisms that define the characteristic motor symptoms of the disease. To this end, assembloids have been successfully employed to recapitulate neuronal pathways between distinct brain regions. However, the investigation and characterization of these connections through neural tracing and electrophysiological analysis remain a technically challenging and time-consuming process. Here, we present a novel bioengineered platform consisting of surface-grown midbrain and striatal organoids at opposite sides of a self-assembled DA pathway. In particular, dopaminergic neurons and striatal GABAergic neurons spontaneously form DA connections across a microelectrode array (MEA), specifically integrated for the real-time monitoring of electrophysiological development and stimuli response. Calcium imaging data showed spiking synchronicity of the two organoids forming the inter-organoid pathways (IOPs) demonstrating that they are functionally connected. MEA recordings confirm a more robust response to the DA neurotoxin 6-OHDA compared to midbrain organoids alone, thereby validating the potential of this technology to generate highly tractable, easily extractable real-time functional readouts to investigate the dysfunctional dopaminergic network of PD patients.http://www.sciencedirect.com/science/article/pii/S2590006424000516
spellingShingle Alp Ozgun
David J. Lomboni
Amy Aylsworth
Allison Macdonald
William A. Staines
Marzia Martina
Michael G. Schlossmacher
Joseph S. Tauskela
John Woulfe
Fabio Variola
Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
Materials Today Bio
title Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
title_full Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
title_fullStr Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
title_full_unstemmed Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
title_short Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
title_sort unraveling the assembloid real time monitoring of dopaminergic neurites in an inter organoid pathway connecting midbrain and striatal regions
url http://www.sciencedirect.com/science/article/pii/S2590006424000516
work_keys_str_mv AT alpozgun unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT davidjlomboni unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT amyaylsworth unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT allisonmacdonald unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT williamastaines unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT marziamartina unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT michaelgschlossmacher unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT josephstauskela unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT johnwoulfe unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions
AT fabiovariola unravelingtheassembloidrealtimemonitoringofdopaminergicneuritesinaninterorganoidpathwayconnectingmidbrainandstriatalregions